Boro Dropulić, Vector BioMed CEO
January 31, 2023 12:53 PM EST
Financing
Startups
Pharma
Manufacturing

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

Tyler Patchen

News Reporter

The man­u­fac­ture of lentivi­ral vec­tors has been grab­bing the at­ten­tion of in­vestors both small and large as of late, and an­oth­er man­u­fac­tur­er is look­ing to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

A service from the Financial Times